The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 8 , ISSUE 5 ( July, 2007 ) > List of Articles

RESEARCH ARTICLE

An Anticalculus Dentifrice with Sodium Hexametaphosphate and Stannous Fluoride: A Six-month Study of Efficacy

J. Leslie Winston, Thomas Schiff, Susan K. Fiedler, Robert A. Baker

Citation Information : Winston JL, Schiff T, Fiedler SK, Baker RA. An Anticalculus Dentifrice with Sodium Hexametaphosphate and Stannous Fluoride: A Six-month Study of Efficacy. J Contemp Dent Pract 2007; 8 (5):1-8.

DOI: 10.5005/jcdp-8-5-1

License: CC BY-NC 3.0

Published Online: 01-09-2008

Copyright Statement:  Copyright © 2007; The Author(s).


Abstract

Aim

To compare the anticalculus efficacy of an experimental dentifrice (0.454% stabilized stannous fluoride/ sodium hexametaphosphate) with a negative control.

Methods and Materials

This was a randomized, examiner-blind, parallel group study. After a three-month run-in, qualifying subjects were randomized to the experimental or control dentifrice to use twice a day for six months. Volpe-Manhold Index (V-MI) and oral soft tissue examinations were conducted at baseline, three, and six months. Additional analyses were performed separately at three and six months on three subgroups categorized into high, medium, and low calculus-forming subjects.

Results

Compared to the control group, the experimental dentifrice group had a mean calculus score statistically significantly lower at both three months (50%) and six months (55%) post-treatment (p<0.001). Compared to control scores, mean experimental dentifrice calculus scores at three and six months were statistically significantly lower at both points in time for high, medium, and low calculus forming sub-groups (p<0.001). Both products were generally well tolerated.

Conclusion

The experimental dentifrice revealed significant anticalculus efficacy compared to the control regardless of levels of baseline calculus formation.

Clinical Significance

The stannous fluoride/sodium hexametaphosphate dentifrice technology is an effective calculus inhibitor for home care.

Citation

Winston JL, Fiedler SK, Schiff T, Baker RA. An Anticalculus Dentifrice with Sodium Hexametaphosphate and Stannous Fluoride: A Six-month Study of Efficacy. J Contemp Dent Pract 2007 July;(8)5:001-008.


PDF Share
  1. Calculus formation and prevention: an overview. Compend Contin Educ Dent 1987;8(suppl 8):S235-S241.
  2. Periodontal status in the United States, 1988. 1991: prevalence, extent, and demographic variation. J Dent Res 1996;75(spec no):672-681
  3. Why does supragingival calculus form preferentially on the lingual surface of the 6 lower anterior teeth? J Can Dent Assoc 72:923-926, 2006
  4. Processes contributing to the formation of dental calculus. Biofouling. August 1991;7:209-218
  5. Tartar control: assessment of patient benefits and professional scaling advantages. J Clin Dent 1996;7(2 spec no):27-31.
  6. Anticalculus Effects of a Novel, Dual-Phase Polypyrophosphate Dentifrice: Chemical Basis, Mechanism, and Clinical Response. J Contemp Dent Pract 2000;(1)4: 001-019.
  7. Progress regarding the use of stannous fluoride in clinical dentistry. J Clin Dent 1995;6:37-40.
  8. Comparison of SnF2 and NaF mouth rinses on caries incidence, salivary s.mutans, and gingivitis, in high caries prevalent adults. Scand J Dent Res 1985;93:213-217.
  9. Eighteen-month evaluation of the effects of a 0.4% stannous fluoride gel on gingivitis in orthodontic patients. Am J Orthod Dentofacial Orthop 1994;105:35-41
  10. The clinical effect of dentifrices containing stabilized stannous fluoride on plaque formation and gingivitis. a six-month study with ad libitum brushing. J Clin Dent 6 1995 (Spec Issue) 46-53.
  11. A new and improved .dual action. whitening dentifrice technology. sodium hexametaphosphate. J Clin Dent 2002;13:1-5.
  12. In vitro studies of the anticalculus efficacy of a sodium hexametaphosphate whitening dentifrice. J Clin Dent 2002;13:33-37.
  13. The relative anticaries effectiveness of three fluoride-containing dentifrices in Puerto Rico. Caries Res 2004 Nov-Dec;38(6):542-50.
  14. Anticalculus efficacy and safety of a stabilized stannous fluoride/sodium hexametaphosphate dentifrice. Compend Contin Educ Dent 2005;9 (suppl 1):29-34.
  15. Antigingivitis efficacy of a stabilized stannous fluoride/sodium hexametaphosphate dentifrice in subjects previously non-responsive to a triclosan/copolymer dentifrice. Compend Contin Educ Dent 2005;26(supp 1):12-18.
  16. Sustained antibacterial actions of a new stabilized stannous fluoride dentifrice containing sodium hexametaphosphate. Compend Contin Educ Dent 2005;26(supp 1):19-28.
  17. Desensitizing effect of a stabilized stannous fluoride/sodium hexametaphosphate dentifrice. Compend Contin Educ Dent 2005;26(supp 1):35-40.
  18. Anticaries potential of a stabilized stannous fluoride/sodium hexametaphosphate dentifrice. Compend Contin Educ Dent 2005;26(supp 1):41-46.
  19. Extrinsic whitening effects of sodium hexametaphosphate. a review including a dentifrice with stabilized stannous fluoride. Compend Contin Educ Dent 2005;26(supp 1):47-53.
  20. In vivo calculus assessment: Part 1. A method and its examiner reproducibility. J Periodontol 1965;36:299-304.
  21. Anticalculus efficacy and safety of a novel whitening dentifrice containing sodium hexametaphosphate: a controlled six-month clinical trial. J Clin Dent 2002;13:25-28.
  22. Effect of daily rinsing with stannous fluoride on plaque and gingivitis: Final report. 1984; J Dent Res 63:1083-1086.
  23. Effect of toothbrushing with 0.4% stannous fluoride and 0.22% sodium fluoride gel on gingivitis for 18 months. J Am Dent Assoc 1989;119:283-289.
  24. Agents for the management of plaque and gingivitis. J Dent Res 1992;71:1450-1454.
  25. A novel dentifrice technology for advanced oral health protection: a review of technical and clinical data. Compend Contin Educ Dent 2005;26(supp 1):4-11.
  26. A .return. to stannous fluoride dentifrices. J Clin Dent 1995;6:29-36.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.